The small GTPase Rap1 contributes to fear learning and cortico-amygdala plasticity by inhibiting glutamate release from cortical neurons, but mechanisms of this inhibition remain unknown. Conversely, L-type calcium channels (LTCCs) become involved in glutamate release after fear learning and LTP induction. Here, we show that Rap1 deletion in mouse primary cortical neurons increases synaptic vesicle exocytosis without altering endocytosis or vesicle pool size in an LTCC-dependent manner. We identify Erk1/2 as the downstream effector of Rap1 and show that its inhibition increases plasma membrane expression of LTCCs near presynaptic terminals. We propose that the Rap1 signaling enables plasticity and fear learning by regulating LTCCs at cortico-amygdala synapses.
Introduction
The small GTPase Rap1 regulates synaptic plasticity, learning, and memory by integrating and relaying information about changes in neuronal depolarization or the presence of growth factors. These changes cause protein kinase A, GTP exchange factors (GEFs), or GTPase activating proteins (GAPs) to modify Rap1 activity, which regulates various downstream effectors (Gloerich and Bos, 2011) . The role of Rap1 signaling in postsynaptic plasticity is well studied. RAP-GEFs and RAP-GAPs shape spine remodeling (Xie et al., 2005; Spilker and Kreutz, 2010; Lee et al., 2011b) . Rap1 acting through p38 -mitogen-activated protein (MAP) kinase facilitates AMPA receptor endocytosis (Stornetta and Zhu, 2011) . In contrast, the presynaptic role of Rap1 is unclear. We showed recently that Rap1 inhibits basal neurotransmitter release in the cortical input to the lateral amygdala and enables cortico-amygdala plasticity and fear learning (Pan et al., 2008) . Here, using mouse primary cortical neurons, we have identified Erk1/2 signaling and L-type calcium channels (LTCCs) as the downstream Rap1 effectors that mediate suppression of neurotransmitter release, which is a potential mechanism for Rap1 involvement in corticoamygdala plasticity and fear learning.
Materials and Methods
Chemicals were from Sigma or Invitrogen. U0126 [1,4-diamino-2,3-dicyano-1,4-bis(o-aminophenylmercapto)butadiene] and bafilomycin were from EMD Chemicals.
Cell culture, transfection, and viral infection. Dissociated cells from cortices of E16 embryonic mice brain from both sexes were plated on glass coverslips and transfected on DIV 5 (synaptophluorin experiments) or DIV 11, as described previously (Subramanian and Morozov, 2011) . The estimated cotransfection efficiency was 100% (data not shown), yet lower efficiency would only underestimate the significance of the results. Viral infection was performed on DIV 5.
DNA constructs and lentivirus. The following constructs were obtained as gifts; synaptophluorin (Gero Miesenbock, University of Oxford, Oxford, UK), B-Raf wild type (WT) and M483-B-Raf mutant (Deborah Morrison, National Cancer Institute, Fredrick, MD), and TN-XXL (Oliver Griesbeck, Max Planck Institute of Neurobiology, Martinsried, Germany). Rap1B-pBK-CMV phagemid for expressing Rap1B was isolated from a mouse hippocampal cDNA library, and the N17-Rap1B-pBK-CMV was derived from Rap1B-pBK-CMV. The lentivirus transfer vector SIN-W-PGK-Cre was made by cloning a Cre DNA fragment between BamHI and XhoI sites of SIN-W-PGK transfer vector. Lentivirus was concentrated to the titer of 5 ϫ 10 8 transduction units per milliliter.
Live imaging and analyses. Imaging was performed using Carl Zeiss Axiovert 200M microscopes coupled to a spinning-disk confocal scan head Ultraview RS (PerkinElmer Life and Analytical Sciences). Neurons were imaged at DIV 13-DIV 15 as described previously (Subramanian and Morozov, 2011) . Electrical stimulation was delivered through platinum electrodes (10 V, 1 ms pulses at 10 Hz). NH 4 Cl (50 mM) and sucrose (500 mM) were delivered through perfusion. Bouton fluorescence was obtained from 10 ϫ 10 pixels ROIs drawn over randomly selected boutons from one cell (Subramanian and Morozov, 2011) . For synaptophluorin experiments, the change in fluorescence (dF) at a given time point was obtained by subtracting baseline fluorescence (average fluorescence for the five time points before stimulation) from the fluorescence at that time point. For bafilomycin experiments, dF was normalized to the average dF of the last five time points during stimulation in the presence of bafilomycin. Forster resonance energy transfer (FRET) ratio dR/R0 was calculated as ((R Ϫ R0)/R0) ϫ 100, where R is the ratio of cyan fluorescent protein (CFP) to citrine fluorescence, R0 is the average R from five time points before stimulation, and dR ϭ R Ϫ R0.
Boutons that did not respond to stimulation or did not show fluorescence decay after stimulation was stopped were eliminated from analysis. dF in bafilomycin and nitrendipine (NIT) experiments is not directly comparable with dF in other experiments because they were performed using different setups. dF and dR/R0 of a single cell were means from 7-10 boutons. For synaptophluorin experiments, electrical stimulation lasted 18 s, and the dFs at 6 s of stimulation were compared (unless mentioned otherwise). Statistical significance was determined by Student's t test; repeated-measures ANOVA or one-way ANOVA followed by Dunnett's multiple comparison post hoc test using values obtained from individual cells.
Immunofluorescence. Cells were fixed with 4% PFA plus 4% sucrose and permeabilized with 0.1% Triton X-100. After blocking with 10% donkey serum (Jackson ImmunoResearch), cells were incubated with primary antibody overnight at 4°C and secondary antibody for 1 h at room temperature (RT). The primary antibodies were chicken anti-GFP (1:1000; Millipore); rabbit anti-Cre (1:1000; a gift from Christoph Kellendonk, Columbia University, New York, NY); mouse anti-phosphop42,44 MAP kinase and rabbit anti-p42,44 MAP kinase (Cell Signaling Technology); mouse anti-MAP2 (1:200, Sigma); and rabbit-anti Cav1.2 (1:50; Millipore). Secondary antibodies were Cy3-conjugated antimouse, Cy5-conjugated anti-rabbit, or DyLight 488 conjugated antichicken antibodies (1:100; Jackson ImmunoResearch). Cells were imaged using a Carl Zeiss LSM 510 microscope with 63ϫ Plan Apochromat (1.4 numerical aperture) objective.
The phospho-Erk1/2 to total Erk1/2 ratio from immunofluorescence signals was normalized to the average ratio obtained with WT cells treated with U0126 (MEK inhibitor). To enhance the immunofluorescence signal of phospho-Erk1/2, we treated the cells with KCl before fixation.
Western blot and genomic PCR. Cells were lysed and centrifuged for 10 min at 12,000 ϫ g at 4°C (Subramanian and Morozov, 2011) . The supernatant was used for Western blot. The polyvinylidene difluoride membrane (Millipore) was blocked with 1% BSA (for Rap1 detection) or 5% dry milk (for Erk1/2 detection) for 1 h at RT and incubated with primary antibody (mouse anti-Rap1, 1:250, BD Biosciences; or rabbit anti-p42,44 MAP kinase antibody, 1:1000, Cell Signaling Technology) at 4°C overnight. The membrane was incubated at RT for 1 h with HRP-conjugated anti-rabbit or anti-mouse antibody (Jackson ImmunoResearch). The protein bands were visualized using LumiGLO reagent (Cell Signaling Technology). The pellet was used for genomic PCR as described previously (Pan et al., 2008) .
Electron microscopy. Cortical neurons cultured on Aclar embedding film (Ted Pella) were treated with DMSO or U0126 for 20 min and fixed with 4% paraformaldehyde and 0.1% glutaraldehyde in PBS. After permeabilization with 0.1% Triton X-100 for 5 min at RT, cells were incubated with anti-Cav1.2 antibody (1:50; Millipore; omitted for negative control) and normal goat serum overnight at 4°C. After washing, the cells were incubated in anti-rabbit nanogold secondary antibody (1:100; Nanoprobes) overnight at 4°C. After silver enhancement (HQ silver enhancement kit; Nanoprobes), cells were postfixed with 0.2% osmium tetroxide for 1 h at RT and treated with 0.25% uranyl acetate for 1 h at 4°C. After dehydration, cells were embedded in 100% resin, and 70-nmthick sections were prepared on a Reichert-Jung Ultracut-E ultramicrotome and placed on LuxFilm grids with a 2.0 mm open area and a 30 nm support film (Ted Pella). The grids were post-stained with uranyl acetate and lead citrate. Axons containing synaptic vesicles (SVs) and positive for immunogold labeling were imaged in a Jeol 1400 transmission electron microscope operating at 80 kV.
Results

Rap1 deletion in primary neurons increases exocytosis without altering endocytosis or vesicle pool size
We first confirmed, by using lentiviral expression, that Cre recombinase in neurons with double-floxed rap1a and rap1b alleles (Pan et al., 2008) effectively excises floxed regions in both genes and eliminates Rap1 protein (Fig. 1A) . We then compared the synaptophluorin response dF, a measure of exocytosis (Miesenböck et al., 1998) , in axons of neurons chemically transfected with a construct expressing synaptophluorin (WT) or constructs expressing synaptophluorin and Cre recombinase [knock-out (KO)] (Fig. 1B) .
We induced exocytosis by 60 s field electrical stimulation (Fig. 1C,D) . During early phase of stimulation, at 6 s, dF in KO was 95% higher than in WT terminals (Fig. 1D) . However, during the later phase, at 60 s, the dF was similar for both genotypes (Fig. 1D) .
To confirm that the increase in dF in Cre-transfected cells resulted from loss of Rap1, we cotransfected constructs expressing either Rap1B or its inactive mutant N17Rap1B (N17) (Vossler et al., 1997) along with Cre and synaptophluorin. Rap1B reduced dF in KO terminals to WT levels but had no effect in WT terminals; in contrast, N17 had no effect on dF in KO axons (Fig.  1E ). These results show that Rap1B expression rescues Rap1 KO phenotype.
Next we tested whether the increased dF in KO neurons resulted from increased exocytosis or decreased endocytosis. In the presence of bafilomycin, which blocks vesicle reacidification, dF is a direct measure of exocytosis. Endocytosis can be quantified as the difference between dF in the presence and absence of bafilomycin (Burrone et al., 2006) . We first treated WT or KO neurons with DMSO for 15 min and measured dF during 30 s stimulation. After another 15 min in DMSO and 1 min after addition of bafilomycin, same boutons were reimaged during 90 s stimulation ( Fig. 2A) . The time constant of exocytosis determined from a single-exponential fit of the dF in the presence of bafilomycin was 15.2 Ϯ 1.3 s for KO and 27.4 Ϯ 2.9 s for WT ( p ϭ 0.009, t test) indicating that exocytosis is faster in the absence of Rap1.
At the end of the 90 s stimulation, both genotypes had similar dFs (KO, 716.2 Ϯ 132.3; WT, 782.2 Ϯ 142.5; p ϭ 0.75, t test), suggesting that total recycling pool is similar between genotypes. The level of endocytosis was not significantly different between the two genotypes at all time points (Fig. 2 A, B) .
We next looked at the vesicle pool size, which may influence exocytosis rate. To test the total vesicle pool, we measured increase in fluorescence caused by NH 4 Cl, which reversibly raises the internal pH and enables synaptophluorin fluorescence in all SVs (Sankaranarayanan et al., 2000) . The increase in fluorescence did not differ between WT and KO terminals (Fig. 2C) . The readily releasable pool (RRP) exocytoses by hyperosmotic shock with sucrose (Rosenmund and Stevens, 1996) , which produced the same fluorescence increase in both genotypes (Fig. 2D) . These results indicate that sizes of total and RRP are not altered by Rap1 deletion.
Rap1-B-Raf-Erk1/2 pathway suppresses exocytosis
In neurons, Rap1 activates Erk1/2 through B-Raf and MEK (Fig.  3A) (York et al., 1998) . We recently found that Erk1/2 inhibition by U0126 enhances SV exocytosis (Subramanian and Morozov, 2011) . Because both Rap1 deletion and Erk1/2 inhibition enhanced exocytosis, we tested whether these proteins were acting through the same pathway. We first confirmed that interference with Rap1 or B-Raf function reduces Erk1/2 phosphorylation. We quantified phospho-Erk1/2 in KCl-induced neurons expressing Cre (KO neurons) or a dominant-negative B-Raf-K483M (Wan et al., 2004 ) by immunofluorescence. When compared with WT cells, the phospho-Erk1/2 to total Erk1/2 fluorescence ratio was lower in both KO and B-Raf-K483M cells but not in WT B-Raf construct transfected cells (Fig. 3 B, C) .
If Rap1 and Erk1/2 acted through the same pathway, the Rap1 deletion would occlude the effect of Erk1/2 inhibition by U0126. At 2 mM external Ca 2ϩ , U0126 increased dF in WT cells by 65% but had no significant effect in KO cells (Fig. 3D) , suggesting that Erk1/2 and Rap1 suppress exocytosis via a shared pathway. Alternatively, Rap1 and Erk1/2 might act independently, but exocytosis reached a ceiling in the absence of Rap1 and masked the effect of U0126. To avoid ceiling effects, we decreased external Ca 2ϩ concentration to 1 mM, which reduced dF by half. Under these conditions, U0126 increased dF by 220% in WT terminals but only by 25% in KO (Fig. 3E) . The effect of U0126 in KO was significantly lower than in WT ( p ϭ 0.016). These data suggest that inhibition of exocytosis by Erk1/2 depends primarily, but not exclusively, on the pool of Erk1/2 that is activated through the Rap1-dependent pathway. Because Rap1 activates Erk1/2 via B-Raf (Ohtsuka et al., 1996) , an interference with B-Raf activity should also enhance exocytosis. Consistently, the dominantnegative B-Raf increased dF by 45%, whereas the WT B-Raf had no effect (Fig. 3F ) . Together, these data indicate that interference with the Rap1-B-Raf-MEK-Erk1/2 pathway enhances exocytosis.
Rap1 deletion increases calcium influx in axons through Erk1/2
Next we examined the mechanism by which Rap1 deletion enhances SV exocytosis. Because the vesicle pool size was not altered in KO neurons, we tested whether calcium level was higher in axons during electrical stimulation. We used TN-XXL, a FRETbased genetic indicator of calcium (Mank and Griesbeck, 2008) (Fig. 4A) . Electrical stimulation reduced CFP and increased citrine fluorescence of TN-XXL, thus increasing the FRET ratio dR/R0 (Fig. 4A) . We imaged axons of neurons transfected with TN-XXL construct alone (WT) or together with Cre (KO). During 6 s electrical stimulation, dR/R0 increase was significantly higher in KO than in WT axons (KO vs WT; ANOVA, F (1,7) ϭ 3.4; p ϭ 0.002; n ϭ 10 (WT) and 10 (KO); Fig. 4B ), indicating that deletion of Rap1 increases axonal calcium influx during activity. Because inhibition of Erk1/2 also increases axonal calcium (Subramanian and Morozov, 2011), we examined effect of U0126 on dR/R0 in KO axons. U0126 significantly increased dR/R0 in WT cells (WT ϩ U0126 vs WT; dR/R0 ϫ treatment interaction; ANOVA, F (1,7) ϭ 3.1; p ϭ 0.006; n ϭ 6 per group) but not in KO cells (F (1,7) ϭ 1.6; p ϭ 0.15; n ϭ 7 per group) (Fig. 4C) . These results suggest that Rap1 acts via Erk1/2 in suppressing axonal calcium influx.
We showed previously that, in cells pretreated with LTCC blocker NIT, U0126 does not increase FRET response (Subramanian and Morozov, 2011) . Surprisingly, NIT did not reduce the elevated dR/R0 in Rap1 KO or cells that were pretreated with U0126 (data not shown; see Discussion). However, a 15 min treatment of neurons expressing synaptophluorin with NIT (Fig.  4D ) reversibly reduced dF in KO neurons but not in WT neurons (Fig. 4D) , which suggests that Rap1-Erk1/2 signaling pathway reduces neurotransmitter release by suppressing LTCCs.
To determine whether Erk1/2 signaling alters LTCC expression, we quantified the ratio between Cav1.2 and MAP2 immunofluorescence in dendritic segments (Fig. 4E ) of cells treated with DMSO or U0126. We found no difference between the two conditions (DMSO, 0.59 Ϯ 0.004, n ϭ 60 segments; U0126, 0.54 Ϯ 0.003, n ϭ 59 segments; p ϭ 0.2, t test), suggesting that the change in LTCC protein expression levels is not required for the observed phenotype.
We showed that Erk1/2 inhibition enhances surface fraction of Cav1.2 in the soma (Subramanian and Morozov, 2011) . However, immunofluorescence does not detect Cav1.2 in axons, and it is unclear whether these channels are present near presynaptic terminals. To this end, we performed Cav1.2 immunoelectron microscopy of DMSO-or U0126-treated neurons. We analyzed axonal regions that contain SVs (Fig. 4F ) and calculated the numeric ratio between immunogold particles on the membrane and in the cytoplasm. The ratio was 2.2-fold higher in U0126-treated than in DMSO-treated neurons (U0126, 59 Ϯ 9.5%, n ϭ 19 profiles; DMSO, 26.2 Ϯ 8.9%, n ϭ 15 profiles; p ϭ 0.01). These results show that LTCC is present in axons and that Erk1/2 inhibition increases its surface expression.
Discussion
Here, we show that inhibition of Rap1 signaling increases LTCCdependent SV exocytosis. Active Rap1 interacts with multiple effectors, including Ral-GDS, a GEF for Ral A, and B-Raf, an activator of Erk signaling (Bos et al., 2001 ). Rap1 could modulate exocytosis through Ral A, which has been reported to increase the RRP of SVs (Polzin et al., 2002) . However, KO neurons had a normal RRP, and Rap1 deletion in mice did not change the level of active Ral A in the cortex (data not shown). Therefore, the effect of Rap1 on neurotransmitter release is unlikely to occur via Ral A. Instead, our findings suggest that Rap1 suppresses neurotransmitter release through B-Raf-Erk signaling. This is in contrast to the Ras-Erk1/2 signaling that increases neurotransmitter release through synapsin phosphorylation (Kushner et al., 2005) . Rap1 and Ras have been shown to play an antagonistic role (Stork, 2003; Lee et al., 2011a) . With respect to neurotransmitter release, they do so by activating the same intermediate Erk1/2, raising an interesting possibility that different pools of Erk1/2 play opposing roles in neurotransmitter release.
Erk1/2 inhibition increases LTCC contribution to neurotransmitter release (Subramanian and Morozov, 2011) . Consistent with the idea that Rap1 acts via the Erk1/2-LTCC pathway, the increased dF in KO was attenuated by the LTCC blocker NIT. The rescue of dF, but not dR/R0, in KO by NIT can be attributable to the fact that NIT binds only to the inactive conformation of the channel (Hess et al., 1984) . LTCCs become inactivated through calcium/voltage-dependent mechanisms, which require strong and lasting depolarization. Thus, when applied acutely, NIT does not inhibit LTCCs during first 30 action potentials of a 100 Hz stimulation but inhibits it significantly after 60 action potentials (Helton et al., 2005) . Similarly, in our experiments, NIT is unlikely to block LTCCs during the first 30 stimuli of even lower frequency of 10 Hz. Because dR/R0 response saturates within 30 action potentials, it is not influenced by changes in calcium influx from NIT block of LTCCs. Conversely, synaptophluorin enables detection of NIT effect on presynaptic release after 60 stimuli because LTCCs become available for NIT blockade. It is unclear how the presence of NIT before and during U0126 treatment was able to prevent the enhancement of dR/R0 (Subramanian and Morozov, 2011) . Possibly, previous electrical stimulation in the presence of NIT was sufficient to inactivate LTCCs introduced by U0126 exposure.
Rap1-Erk signaling can promote LTCC-dependent neurotransmitter release through changes in surface expression and/or gating properties of either Cav1.2 or Cav1.3 channels. Although we did not distinguish between Cav1.2 and Cav1.3 channels, the immunoelectron microscopy of Cav1.2 channels suggests that changes in surface fraction of these channels could be a potential mechanism by which Rap1 regulates neurotransmitter release.
LTCC-dependent neurotransmitter release is enhanced after fear learning or induction of presynaptic plasticity (ShinnickGallagher et al., 2003; Fourcaudot et al., 2009) . Meanwhile, the plasticity and learning deficits in Rap1 KO mice likely result from elevated LTCC-dependent neurotransmitter release. We propose that Rap1-Erk1/2 signaling enables fear learning by suppressing basal LTCC-dependent release of glutamate and thereby reducing the detection threshold of activity at cortico-amygdala synapses.
